5-MeO-MiPT

From WikiMD's WELLNESSPEDIA

5-MeO-MiPT[edit]

Chemical structure of 5-MeO-MiPT
3D model of 5-MeO-MiPT
5-MeO-MiPT in powder form

5-MeO-MiPT (5-methoxy-N-methyl-N-isopropyltryptamine) is a synthetic psychedelic compound belonging to the tryptamine class. It is known for its psychoactive effects and is used recreationally for its hallucinogenic properties.

Chemical Structure[edit]

5-MeO-MiPT is a tryptamine derivative, characterized by the presence of a methoxy group at the 5-position of the indole ring. Its chemical formula is C15H22N2O, and it has a molecular weight of 246.35 g/mol. The compound is structurally related to other tryptamines such as 5-MeO-DMT and MiPT.

Pharmacology[edit]

5-MeO-MiPT acts primarily as a serotonin receptor agonist, particularly at the 5-HT2A receptor, which is believed to be responsible for its psychedelic effects. It may also interact with other serotonin receptors, contributing to its complex pharmacological profile.

Effects[edit]

The effects of 5-MeO-MiPT can vary depending on the dose and individual sensitivity. Common effects include:

  • Altered perception of time and space
  • Enhanced sensory perception
  • Euphoria
  • Visual and auditory hallucinations
  • Increased introspection

Dosage and Administration[edit]

5-MeO-MiPT is typically administered orally or via insufflation. The threshold dose is around 2-4 mg, with common doses ranging from 5-15 mg. Effects can last from 4 to 6 hours, with onset occurring within 20 to 40 minutes after ingestion.

Safety and Toxicity[edit]

The safety profile of 5-MeO-MiPT is not well-established, and its use carries potential risks. Users may experience adverse effects such as anxiety, paranoia, and nausea. There is limited data on its long-term effects and potential for addiction.

Legal Status[edit]

The legal status of 5-MeO-MiPT varies by country. In some jurisdictions, it is classified as a controlled substance, while in others, it remains unscheduled. Users should be aware of the legal implications of possessing or using this compound in their region.

Related Compounds[edit]

See Also[edit]

Gallery[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=5-MeO-MiPT&oldid=6619597"